摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(tert-butoxycarbonyl)-α-hydroxymethyl-DL-phenylalanine | 833484-32-5

中文名称
——
中文别名
——
英文名称
N-(tert-butoxycarbonyl)-α-hydroxymethyl-DL-phenylalanine
英文别名
2-Benzyl-2-{[(tert-butoxy)carbonyl]amino}-3-hydroxypropanoic acid;2-benzyl-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
N-(tert-butoxycarbonyl)-α-hydroxymethyl-DL-phenylalanine化学式
CAS
833484-32-5
化学式
C15H21NO5
mdl
——
分子量
295.335
InChiKey
ZFGWMKJMZBKYID-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    491.2±45.0 °C(Predicted)
  • 密度:
    1.218±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    95.9
  • 氢给体数:
    3
  • 氢受体数:
    5

SDS

SDS:71aed0835d714f3b08766f875f85ee9c
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(tert-butoxycarbonyl)-α-hydroxymethyl-DL-phenylalanine 在 palladium on activated charcoal 盐酸氢气三甲基铝三乙胺三苯基膦 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 偶氮二甲酸二乙酯 作用下, 以 四氢呋喃甲醇二氯甲烷乙酸乙酯N,N-二甲基甲酰胺甲苯 为溶剂, 反应 3.0h, 生成 (S)-2-Acetylamino-N-(3-benzyl-1-methylamino-2-oxo-azetidin-3-yl)-propionamide
    参考文献:
    名称:
    A general strategy for the synthesis of azapeptidomimetic lactams
    摘要:
    A selection of azapeptidomimetics containing constraining lactam rings have been prepared by Mitsunobu cyclization of serine/ homologated serine-azaalanine derivatives. These include sterically-congested beta-lactams, as well as gamma-butyrolactam and delta-valerolactam analogs. A novel azaamino acid acylation method was developed to prepare the sterically demanding alpha-benzyl-serine-azaalanine precursor. In all cases, the Mitsunobu conditions were highly efficient in forming the desired azapeptidomimetic lactams. The reported process represents a general strategy for the synthesis of peptidomimetic structures with a constraining lactam ring. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2005.08.029
  • 作为产物:
    描述:
    L-苯丙氨酸乙酯盐酸盐盐酸 、 lithium hydroxide 、 正丁基锂碳酸氢钠 、 magnesium sulfate 、 三乙胺二异丙胺 作用下, 以 四氢呋喃乙醇正己烷二氯甲烷 为溶剂, 反应 8.5h, 生成 N-(tert-butoxycarbonyl)-α-hydroxymethyl-DL-phenylalanine
    参考文献:
    名称:
    A general strategy for the synthesis of azapeptidomimetic lactams
    摘要:
    A selection of azapeptidomimetics containing constraining lactam rings have been prepared by Mitsunobu cyclization of serine/ homologated serine-azaalanine derivatives. These include sterically-congested beta-lactams, as well as gamma-butyrolactam and delta-valerolactam analogs. A novel azaamino acid acylation method was developed to prepare the sterically demanding alpha-benzyl-serine-azaalanine precursor. In all cases, the Mitsunobu conditions were highly efficient in forming the desired azapeptidomimetic lactams. The reported process represents a general strategy for the synthesis of peptidomimetic structures with a constraining lactam ring. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2005.08.029
点击查看最新优质反应信息

文献信息

  • A general strategy for the synthesis of azapeptidomimetic lactams
    作者:Robert L. Broadrup、Bei Wang、William P. Malachowski
    DOI:10.1016/j.tet.2005.08.029
    日期:2005.10
    A selection of azapeptidomimetics containing constraining lactam rings have been prepared by Mitsunobu cyclization of serine/ homologated serine-azaalanine derivatives. These include sterically-congested beta-lactams, as well as gamma-butyrolactam and delta-valerolactam analogs. A novel azaamino acid acylation method was developed to prepare the sterically demanding alpha-benzyl-serine-azaalanine precursor. In all cases, the Mitsunobu conditions were highly efficient in forming the desired azapeptidomimetic lactams. The reported process represents a general strategy for the synthesis of peptidomimetic structures with a constraining lactam ring. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多